Status:
RECRUITING
Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)
Lead Sponsor:
Bar-Chama, Natan, M.D.
Conditions:
Fertility Issues
Eligibility:
MALE
18-50 years
Brief Summary
This study will aim to assess the fertility status of men with Spinal Muscular Atrophy (SMA) not on disease-modifying therapies. Participants will: 1. Complete online questionnaires that will assess...
Detailed Description
Study participants will: 1. Complete online questionnaires that will assess SMA diagnosis and disease burden, medical and surgical history, medication usage, and fertility status and perspectives. 2....
Eligibility Criteria
Inclusion
- Signed Informed Consent Form (or assent)
- Male and age greater than 18 years and less than 50 years of age with a confirmed diagnosis of SMA at the time of signing the Informed Consent Form (or assent)
- Currently not on a disease-modifying agent or therapy for SMA
- Adequately recovered from any acute illness at the time of screening, and considered clinically well enough to participate in the study.
Exclusion
- Men with a prior history of chemotherapy, radiation therapy, prostate or testicular cancer, undescended testicles and use of anabolic steroids or testosterone usage will be excluded
Key Trial Info
Start Date :
February 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06194539
Start Date
February 1 2024
End Date
July 1 2026
Last Update
January 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Natan Bar-Chama MD
Cresskill, New Jersey, United States, 07626